|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 217/26 | (2006.01) |
| A61K 31/47 | (2006.01) | ||
| A61P 13/12 | (2006.01) |
| (11) | Number of the document | 3679017 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18742967.5 |
| Date of filing the European patent application | 2018-07-11 | |
| (97) | Date of publication of the European application | 2020-07-15 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/068754 |
| Date | 2018-07-11 |
| (87) | Number | WO 2019/042641 |
| Date | 2019-03-07 |
| (30) | Number | Date | Country code |
| 17189195 | 2017-09-04 | EP | |
| 18165661 | 2018-04-04 | EP |
| (72) |
LENGAUER, Hannes , AT
PICHLER, Arthur , AT
MARGREITER, Renate , AT
GELBRICH, Thomas , AT
|
| (73) |
Sandoz AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | CO-CRYSTAL OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR |
| CO-CRYSTAL OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR |